REVIEW
Published on 22 Jul 2026
Advances and challenges in biomarker guided management of triple-negative breast cancer in the era of neoadjuvant chemo-immunotherapy
doi 10.3389/fonc.2026.1842762
- 1,190 views
Articles
SYSTEMATIC REVIEW
Published on 15 Jul 2026
Neoadjuvant chemotherapy with angiogenesis inhibitor in early-stage breast cancer: a systematic review and meta-analysis
doi 10.3389/fonc.2026.1830676
- 742 views
ORIGINAL RESEARCH
Published on 11 May 2026
Prognostic value of androgen receptor expression in ER-positive/HER2-negative breast cancer: evidence from a contemporary Chinese cohort
doi 10.3389/fonc.2026.1824532
- 1,199 views
ORIGINAL RESEARCH
Published on 20 Apr 2026
Predicting dynamic changes of Ki-67 in breast cancer after neoadjuvant therapy based on multi−phase DCE-MRI delta-radiomics
doi 10.3389/fonc.2026.1793905
- 1,483 views
ORIGINAL RESEARCH
Published on 13 Apr 2026
Survival benefit of neoadjuvant chemotherapy in HR+/HER2− early breast cancer stratified by luminal B status and clinical risk: a real-world cohort study in a Chinese population
doi 10.3389/fonc.2026.1804093
- 1,916 views
CASE REPORT
Published on 13 Feb 2026
Postoperative recurrence and systemic metastasis of large cell neuroendocrine carcinoma of the breast: a case report including T-DXd treatment
doi 10.3389/fonc.2026.1747084
- 1,255 views
